Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Poised To Produce A/H1N1 Vaccine, Sanofi Pasteur Ramping Up Capacity In U.S., Developing Defense For Another Killer Virus

This article was originally published in PharmAsia News

Executive Summary

BEIJING - On standby to rapidly turn out a vaccine for A/H1N1 if the World Health Organization declares a continents-wide pandemic is emerging, scientists at Sanofi Pasteur are also working with the UN group to develop a defense for the tropical dengue virus, which has already killed far more people worldwide than the swine flu

You may also be interested in...



Chinese Government Expects Prepared H1N1 Vaccine By July, But MNCs Say Longer

HONG KONG - The number of cases of swine flu continues to mount across Southeast Asia and the world, but despite what the Chinese government suggests, an effective vaccine is still months away

Chinese Government Expects Prepared H1N1 Vaccine By July, But MNCs Say Longer

HONG KONG - The number of cases of swine flu continues to mount across Southeast Asia and the world, but despite what the Chinese government suggests, an effective vaccine is still months away

Swine Flu Vaccines Likely to Be Shielded From Tort Claims

Vaccine manufacturers are ready to begin producing swine flu vaccines once the government gives them the nod to go forward. As they do so, they may be free from one worry: the risk of being sued for vaccine-related injuries

Related Content

UsernamePublicRestriction

Register

SC071591

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel